Skip to content

Suture hemorrhoidopexy Versus Milligan-Morgan hemorrhoidectomy for Grade 3 and 4 Symptomatic Haemorrhoidal Disease: A Prospective Randomized Controlled Study

Suture hemorrhoidopexy Versus Milligan-Morgan hemorrhoidectomy for Grade 3 and 4 Symptomatic Haemorrhoidal Disease: A Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003686
Enrollment
Unknown
Registered
2013-10-14
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemorrhoidal Disease

Interventions

Experimental:Suture Hemorrhoidopexy
Active Comparator:Milligan-Morgan Hemorrhoidectomy

Sponsors

Pudong New Area Hospital of Traditional Chinese Medicine, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Suffering from symptomatic grade III or IV haemorrhoidal disease and requiring surgery; (2) Patient (male or female) aged 18-85 years; (3) Patients who are able to understand the information given and are willing to give a written consent.

Exclusion criteria

Exclusion criteria: 1. incontinence (Wexner score > 12); 2. Acute complication of haemorrhoidal disease; 3. History of anal surgery for haemorrhoids; 4. Congenital or acquirred anal stenosis; 5. Rectal prolapse or Anal fissure or perianal abcess or Anal fistula; 6. Inflammatory bowel disease or irritable bowel syndrome; 7. Colon or rectal cancerv History of rectal or sigmoid resection; 8. Portal vein hypertension; 9. Haemophylia or Patients taking immunosuppressant medication; 10. Pregnancy or Lactating women; 11. patients combined with severe mental disorders; 12. Patients not able to follow the study protocol or Unwilling or unable to sign informed consent.

Design outcomes

Primary

MeasureTime frame
postoperative pain;analgesics requirement;Early postoperative complications;Late postoperative complications;Intra-operative bleeding;Return to work or normal life;Complete wound healing;Follow-up outcome;Efficacy;

Countries

China

Contacts

Public ContactQi Zhang

Pudong New Area Hospital of Traditional Chinese Medicine, Shanghai

zhq_pdzyy@163.com+86 18217239877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026